In vitro cytotoxicity, chemotactic effect, and cellular uptake of branched polypeptides with poly[L-Lys] backbone by J774 murine macrophage cell line

Bioconjugate Chemistry

Volumn 19, Issue 5, 2008, Pages 1078-1086

  Szabó, Rita ^a   Mezö, Gábor ^a   Pállinger, Éva ^b   Kovács, Péter ^b   Köhidai, László ^b   Bösze, Szilvia ^a   Hudecz, Ferenc ^a,c  

^a EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c EÖTVÖS LORÁND UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; BONE; CELL CULTURE; MACROPHAGES; POLYPEPTIDES;

BONE MARROW; CELLULAR UPTAKE; CHARGE PROPERTIES; CHEMOTAXI; IN-VITRO; MURINE MACROPHAGES; POLYANIONICS; POLYLYSINE; SCAVENGER RECEPTOR; VITRO CYTOTOXICITIES;

MOLECULES;

AMINO ACID; CARBOXYFLUORESCEIN; FUCOIDIN; POLYLYSINE; POLYPEPTIDE; SCAVENGER RECEPTOR;

AMINO ACID ANALYSIS; AMINO ACID COMPOSITION; ANIMAL CELL; ARTICLE; CELL SURVIVAL; CELL TRANSPORT; CHEMICAL STRUCTURE; CHEMOTAXIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG MECHANISM; DRUG RESEARCH; FLOW CYTOMETRY; INTERNALIZATION; NONHUMAN; PROTEIN TRANSPORT; RAT; SYNTHESIS;

MURINAE;

EID: 44349178049     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc7004544     Document Type: Article

References (49)

1. Duncan, R., Gac-Breton, S., Keane, R., Musila, R., Sat, Y. N., Satchi, R., and Searle, F. (2001) Polymer-drug conjugates, PDEPT and PELT: basic principles for design and transfer from the laboratory to clinic. J. Controlled Release 74, 135-146.
2. Abraham, R., Singh, N., Mukhopadhyay, A., Basu, S. K., Baal, V., and Rath, S. (1995) Modulation of immunogenicity and antigenicity of proteins by maleylation to target scavenger receptors on macrophages. J. Immunol. 154, 1-8.
3. Hudecz, F., Reményi, J., Szabǒ, R., Kǒczán, Gy., Mezõ, G., Kovács, P., and Gaál, D. (2003) Drug targeting by macromolecules without recognition unit? J. Mol. Recognit. 16, 288-298.
4. Duncan, R., Kopečkova-Rejmanova, P., Strohalm, J., Hume, I., Cable, H. C., Pohl, J., Lloyd, J. B., and Kopecek, J. (1987) Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. I. Evaluation of daunomycin and puromycin conjugates in vitro. Br. J. Cancer 55, 165-74.
5. Jensen, K. D., Nori, A., Tijerina, M., Kopečkova, P., and Kopeček, J. (2003) Cytoplasmic delivery and nuclear targeting of synthetic macromolecules. J. Controlled Release 87, 89-105.
6. Przybylski, M., Zaharko, D. S., Chirigos, M. A., Adamson, R. H., Schultz, R. M., and Ringsdorf, H. (1978) DIVEMA-methotrexate: immune-adjuvant role of polymeric carriers linked to antitumor agents. Cancer Treat. Rep. 62, 1837-43.
7. Ward, C. M., Read, M. L., and Seymour, L. W. (2001) Systemic circulation of poly(L-lysine)/DNA vectors is influenced by polycation molecular weight and type of DNA: differential circulation in mice and rats and the implications for human gene therapy. Blood 97, 2221-2229.
8. Li, C. (2002) Poly(L-glutamic acid) - anticancer drug conjugates. Adv. Drug Delivery Rev. 54, 695-713.
9. Bourke, S. L., and Kohn, J. (2003) Polymers derived from the amino acid L-tyrosine: polycarbonates, polyarylates and copolymers with poly(ethylene glycol). Adv. Drug Delivery Rev. 55, 447-466.
10. m) substituted poly (L-lysine). Biopolymers 33, 873-85.
11. Mezö, G., Kajtár, J., Nagy, I. B., Szekerke, M., and Hudecz, F. (1997) Carrier design: synthesis and conformational studies of poly(L-lysine) based branched polypeptides with hydroxyl groups in the side chains. Biopolymers 42, 713-730.
12. Hudecz, F. (1995) Design of synthetic branched-chain polypeptides as carriers for bioactive molecules. Anti-Cancer Drugs 6, 171-193.
13. Hudecz, F., Pimm, M. V., Rajnavölgyi, É., Mezö, G., Fabra, A., Gaál, D., Kovács, A. L., Horváth, A., and Szekerke, M. (1999) Carrier design: new generation of polycationic branched polypeptides containing OH groups with prolonged blood survival and diminished in vitro cytotoxicity. Bioconjugate Chem. 10, 781-790.
14. Clegg, J. A., Hudecz, F., Mezö, G., Pimm, M. V., Szekerke, M., and Baldwin, R. W. (1990) Carrier design: biodistribution of branched chain polypeptides with poly(L-lysine) backbone. Bioconjugate Chem. 2, 425-430.
15. 51Cr. J. Controlled Release 37, 161-17.
16. Rajnavölgyi, É., Hudecz, F., Mezö, G., Szekerke, M., and Gergely, J. (1986) Isotype distribution and fine specificity of the antibody response of inbred mouse strains of four compounds belonging to of a new group of synthetic branched polypeptides. Mol. Immunol. 23, 21-37.
17. Mezö, G., Hudecz, F., Kajtár, J., Szókán, Gy., and Szekerke, M. (1989) The influence of the side-chain sequence on the structure-activity correlations of immunomodulatory branched polypeptides. Synthesis and conformational analysis of new model polypeptides. Biopolymers 28, 1801-1826.
18. Gaál, D., Hudecz, F., and Szekerke, M. (1984) Immunomodulatory effect of synthetic branched polypeptides I. J. Biol. Response Modif. 3, 174-84.
19. Szabó, R., Köhidai, L., Mezö, G., and Hudecz, F. (2002) Effect of the polylysine based polymeric polypeptides on the growth and chemotaxis of Tetrahymena pyriformis. J. Bioact. Compat. Polym. 17, 399-415.
20. Szabó, R., Peiser, L., Plüddemann, A., Bösze, Sz., Heinsbroek, S., Gordon, S., and Hudecz, F. (2005) Uptake of branched polypeptides with poly[L-Lys] backbone by bone-marrow culture-derived murine macrophages: the role of the class A scavenger receptor. Bioconjugate Chem. 16, 1442-1450.
21. Nagy, I. B., Hudecz, F., Alsina, M. A., and Reig, F. (2003) Physicochemical characterization of branched chain polymeric polypeptide carriers based on a poly-lysine backbone. Biopolymers 70, 323-335.
22. Szabó, R., Hudecz, F., and Reig, F. (2003) Interfacial interactions between poly [L-lysine]-based branched polypeptides and phospholipid model membranes. J. Colloid Interface Sci. 267, 18-24.
23. Reményi, J., Balázs, B., Tóth, S., Falus, A., Tóth, G., and Hudecz, F. (2003) Isomer-dependent daunomycin release and in vitro antitumour effect of cis-aconityl-daunomycin. Biochem. Biophys. Res. Commun. 303, 556-561.
24. Reményi, J., Csík, G., Kovács, P., Reig, F., and Hudecz, F. (2006) The effect of the structure of branched polypeptide carrier on intracellular delivery of daunomycin. Biochem. Biophys. Acta 1758, 280-289.
25. Kóczán, G., Ghoose, A. C., Mookerjee, A., and Hudecz, F. (2002) Methotrexate conjugate with branched polypeptide influences Leishmania donovani infection in vitro and in experimental animals. Bioconjugate Chem. 13, 518-524.
26. IUPAC-IUB Commision on biochemical nomenclature. (1984) Eur. J. Biochem. 138, 9-37.
27. Mezö, G., Hudecz, F., Kajtár, J., Szókán, Gy., and Szekerke, M. (1989) The influence of the side-chain sequence on the structure-activity correlations of immunomodulatory branched polypeptides. Synthesis and conformational analysis of new model polypeptides. Biopolymers 28, 1801-26.
28. Mezö, G., Votavova, H., Hudecz, F., Kajtár, J., Sponar, J., and Szekerke, M. (1988) Conformation of branched polypeptides: The influence of DL-alanine oligomer spacers in the side chains. Collect. Czech. Chem. Commun. 53, 2843-2853.
29. Mezö, G., Mezõ, I., Pimm, M. V., Kajtár, J., Seprödi, J., Teplán, I., Kovács, M., Vincze, B., Pályi, I., Idei, M., Szekerke, M., and Hudecz, F. (1996) Synthesis, conformation and hormone-related in vitro antitumor activity of a gonadotropin-releasing hormone antagonist-branched polypeptide conjugate. Bioconjugate Chem. 7, 642-650.
30. Peiser, L., Makepeace, K., Plüddemann, A., Savino, S., Wright, J. C., Pizza, M., Rappuoli, R., Moxon, E. R., and Gordon, S. (2006) Identification of neisseria meningitidis nonlipopolysaccharide ligands for class A macrophage scavenger receptor by using a novel assay. Infect. Immun. 74, 5191-5199.
31. Petrak, K. (2005) Essential properties of drug-targeting delivery systems. Drug Discovery Today 10, 1667-1673.
32. Tung, C.-H., and Weissleder, R. (2003) Arginine containing peptides as delivery vectors. Adv. Drug Delivery Rev. 55, 281-294.
33. Mukhopadhyay, A., Mukhopadhyay, B., and Basu, S. K. (1995) Circumvention of multidrug resistance in neoplastic cells through scavenger receptor mediated drug delivery. FEBS Lett. 376, 95-98.
34. Hilbert, Á., Hudecz, F., Mezö, G., Mucsi, I., Kajtár, J., Kurucz, I., Gergely, J., and Rajnavölgyi, É. (1994) The influence of branched polypeptide carriers on the immunogenicity of predicted epitopes of HSV-1 glycoprotein D. Scand. J. Immunol. 40, 609-617.
35. Takaura, Y., and Hashida, M. (1995) Macromolecular drug carrier systems in cancer chemotherapy: mavromolecular pro-drugs. Clin. Rev. Oncol. 18, 207-231.
36. Sautebin, L., Ianaro, A., Rombolà, L., Ialenti, A., Sala, A., and Di Rosa, M. (1999) Cyclooxygenase-2-dwpwndent generation of 8-epiprostaglandin F2a by lipopolysaccharide-activated J774 macrophages. Inflamm. Res. 48, 503-508.
37. Kügler, S., Schüller, S., and Goebel, W. (1997) Involvement of MAP-kinases and -phosphatases in uptake and intracellular replication of Lysteria monocytogenes in J774 macrophage cells. FEMS Mocrobiol. Lett. 157, 131-136.
38. Ralph, P., and Nakoinz, I. (1975) Phagocytosis and cytolysis by a macrophage tumour and its cloned cell line. Nature (London) 257, 393-394.
39. Liang-Takasaki, C.-J., Mäkelä, P. H., and Leive, L. (1982) Phagocytosis of bacteria by macrophages: changing the carbohydrate of lipopolysaccharide alters interaction with complement and macrophages. J. Immunol. 128, 1229-1235.
40. McCloskey, M. A., Fan, Y., and Luther, S. (1999) Chemotaxis of rat mast cells toward adenine nucleotides. J. Immunol. 163, 970-977.
41. Claus, V., Jahraus, A., Tjelle, T., Berg, T., Kirschkei, H., Faulstich, H., and Griffiths, G. (1998) Lysosomal Enzyme Trafficking between Phagosomes, Endosomes, and Lysosomes in J774 Macrophages. J. Biol. Chem. 273, 9842-9851.
42. Hostetter, J., Steadham, E., Haynes, J., Bailey, T., and Cheville, N. (2003) Phagosomal maturation and intracellular survival Mycobacterium avium subspecies paratuberculosis in J774 cells. CIMID 26, 269-283.
43. Wright, E. L., Quenelle, D. C., Suling, W. J., and Barrow, W. W. (1996) Use of mono Mac 6 human monocytic cell line and J774 murine macrophage cell line in parallel antimycobacterial drug studies. Antimicrob. Agents Chemother. 40, 2206-2208.
44. Mukhopadhyay, A., Mukhopadhyay, B., Srivastava, R. K., and Basu, S. K. (1992) Scavenger-receptor mediated delivery of daunomycin elicits selective toxicity towards neoplastic cells of macrophage lineage. Biochem. J. 284, 237-241.
45. Brasseur, N., Langlois, R., La Madeleine, C., Ouellet, R., and van Lier, J. E. (1999) Receptor-mediated targeting of phtalocyanines to macrophages via covalent coupling to native or maleylated bovine serum albumin. Photochem. Photobiol. 69, 345-352.
46. Prasad, V., Hashim, S., Mukhopadhyay, A., Basu, S. K., and Roy, R. P. (1999) Oligonucleotides tethered to a short polyguanylic acid stretch are targeted to macrophages: Enhanced antiviral activity of a vesicular stomatitis virus-specific antisense oligonucleotide. Antimicrob. Agents Chemother. 43, 2689-2696.
47. Heit, B., Tavener, S., Raharjo, E., and Kubes, P. (2002) An intracellular signaling hierarchy determines direction of migration in opposing chemotactic gradients. J. Cell. Biol. 159, 91-102.
48. Mezö, G., Láng, O., Jakab, A., Bai, K. B., Szabó, I., Schlosser, G., Láng, J., Köhidai, L., and Hudecz, F. (2006) Synthesis of oligotuftsin-based branched oligopeptide conjugates for chemotactic drug targeting. J. Pept. Sci. 12, 328-336.
49. de Villiers, W. J., Fraser, I. P., and Gordon, S. (1994) Cytokine and growth factor regulation of macrophage scavenger receptor expression and function. Immunol. Lett. 43, 73-79.